精神分裂症患者的躯体疾病风险及防治进展
摘要
精神分裂症患者具有较高的躯体疾病发病风险,除了分裂症本身以外,不良生活方式和抗精神病药的应用也增加了患者并发躯体疾病的风险。本文就精神分裂症患者的躯体疾病风险和防治策略做一综述。
出处
《国际精神病学杂志》
2010年第3期145-148,共4页
Journal Of International Psychiatry
参考文献14
-
1Joukamaa M, Heliovaara M, Knekt P, et al. Schizophrenia, neuroleptic medication and mortality. Br J Psy-chiatry, 2006 ; 188 : 122 - 127.
-
2Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first - episode, drug - naive patients with schizophrenia. Am J psychiatry, 2003, 160 (2) : 284 -289.
-
3Mukherjee S, Schnur DB, Reddy R. Family history of type 2 diabetes in schizophrenic patients. Lancet, 1989. 1 (8636) : 495.
-
4Gilvarry CM, Sham PC, Jones PB, et al. Family history of autoimmune diseases in psychosis. Schizophr Res. 1996, 19 (1): 33 -40.
-
5Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses, 2004, 62 (2): 309-317.
-
6Thakore JH, Mann JN, Vlahos I, et al. Increased visceral fat distribution in drug naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord. 2002, 26 ( 1) 137 - 141.
-
7Enzi, Gasparo M, Biondetti PR, et al. Subcutaneous and visceral fat distribution according to age, sex and overweight, evaluated by computed tomography. Am J Clin Nutr. 1986, 44 (6): 739-746.
-
8岳英,徐一峰,宋立升,易正辉,卢卫红.吸烟与精神分裂症患者药物疗效、副反应及血药浓度的关系[J].中国临床康复,2005,9(20):44-45. 被引量:11
-
9Mccreadie RG. Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry, 2003, 183: 534- 539.
-
10Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medication. Am J psychiatry, 2004, 161 (9) : 1709 -1711.
二级参考文献5
-
1Desai HD,Seabolt J,Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs 2001;15(6):469-94
-
2Combs DR,Advokat C.Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia, Schizophr Res 2000;46(2-3):129-37
-
3Liao DL,Yang JY,Lee SM,et al.Smoking in chronic schizophrenic inpatients in taiwan. Neuropsychobiology 2002;45(4): 172-5
-
4Salokngas RK,Gender and the use of neuroleptics in schizophrenia. Schizophr Res 2004 ;66(1):41-9
-
5McEvoy JP, Freudenreich O, Wilson WH.Smoking and Therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 1999;46(1):125-9
共引文献10
-
1杜莲,罗庆华.精神分裂症与吸烟行为的关系[J].中国组织工程研究与临床康复,2007,11(17):3411-3414. 被引量:9
-
2张明廉,袁国桢,姚建军,钱永潮,倪素琴,周德祥.吸烟对精神分裂症患者奥氮平血药浓度和疗效及不良反应的影响[J].中华精神科杂志,2007,40(4):221-221. 被引量:4
-
3李英丽,许冬梅,邵静,赵丽俊,王志仁,杨甫德,谭云龙.吸烟行为对男性精神分裂症患者临床结局的影响[J].中华护理杂志,2010,45(1):10-12. 被引量:8
-
4张文跃,韩晓东.吸烟与精神分裂症[J].精神医学杂志,2010,23(4):309-311. 被引量:4
-
5王清峰.奥氮平和利醅酮治疗老年脑卒中后精神行为症状的临床对比分析[J].中国实用医药,2011,6(24):163-164. 被引量:7
-
6汪志良,寻知元.氯氮平药物相互作用研究新进展[J].中华精神科杂志,2012,45(1):55-58. 被引量:16
-
7蔡志刚,兰社红,阳宇.吸烟对精神分裂症患者临床治疗的影响[J].中国医学创新,2012,9(12):150-151. 被引量:2
-
8罗添云,温露月,张笑欢.住院精神病患者戒烟可行性探讨[J].广州医药,2012,43(6):47-48. 被引量:2
-
9张顶强,罗亚农,朱自勇,甘大高.奥氮平的临床应用[J].医学信息,2013(5):404-405. 被引量:1
-
10龚坚,宋伟明,刘灵江,杜香菊,王玉成,刘会国,黄敏芳.吸烟对男性精神分裂症患者喹硫平血药浓度和疗效的影响[J].中国基层医药,2014,21(21):3292-3293. 被引量:2
-
1姚玲玲.精神分裂症患者的躯体疾病风险及防治进展[J].中国医药指南,2013,11(8):579-580. 被引量:2
-
2李宏建.卒中或短暂性脑缺血发作后大剂量阿托伐他汀治疗[J].国际脑血管病杂志,2006,14(10):744-744.
-
3桂军明,谢道俊.胰岛素抵抗与脑梗死的关系及中西医结合防治进展[J].中医药临床杂志,2010,22(11):1024-1026. 被引量:2
-
4张洪,章军建.血管性认知功能障碍防治进展[J].中华实用诊断与治疗杂志,2013,27(11):1048-1050. 被引量:13
-
5袁恩庆,吴宣富,田时雨.急性缺血性脑血管病防治进展[J].新医学,1996,27(9):495-496. 被引量:8
-
6王建芳.依达拉奉防治进展性卒中的作用研究[J].中西医结合心脑血管病杂志,2010,8(12):1454-1455. 被引量:1
-
7陈建超,孙昭胜,李永谦,李晓卫,杨雪辉,毛建辉.动脉瘤破裂后脑血管痉挛的防治[J].河北医药,2008,30(2):251-251.
-
8邹景霞,李巧霞,陈学忠,周明贤,尹芳,苏凯.脑缺血再灌注损伤的中医药防治进展[J].甘肃中医,2009,22(1):74-76. 被引量:2
-
9于天杰,赵国景,冀建明.偏头痛的发病及药物防治进展[J].药学实践杂志,1997,15(1):10-12. 被引量:3
-
10糜屈,沈仲夏.艾司西酞普兰和文拉法辛治疗老年抑郁症的对照研究[J].浙江临床医学,2009,11(1):45-46. 被引量:3